Methinks Stroke Suite is the first CE marked medical device that assists in finding large vessel occlusions (LVO) both hyperdense and not from NCCT and CTA. The software also has the ability to detect Intracerebral hemorrhages (ICH) on NCCT images.
"As a clinician with the dual perspective of a vascular neurologist and neurointerventionalist I am increasingly convinced that the simplest and fastest imaging modalities used to select acute stroke patients for thrombectomy are the ones most clinically beneficial. Methinks, the first company whose vision is to develop this concept into a clinically established paradigm is backed by unique technology and an outstanding team and has the potential to disrupt acute stroke systems of care."
Chairman and Chief of Neurology at Cooper University Healthcare, New Jersey
"Methinks AI permite o diagnostico o mais precoce possivel para a indicação de trombectomia em AVC. Eficiência essencial quando cada segundo que passa faz a diferença na vida de nossos pacientes."
Director Stroke Network Advocate Aurora Health, US
"Methinks is already working for research purposes at Hospital Vall d'Hebron. The results we are seeing are outstanding and make us optimistic about the future of this technology."
Stroke Neurologist, and Interventionalist, Hospital Vall d'Hebron, Barcelona